s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
ARS
Annual report to security holders
Filed
Friday, May 5, 2023
Period
Dec 31, 2022
Accession number
0001140361-23-023076
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header